PBM
Propel Bio Management Portfolio holdings
AUM
$82.4M
This Quarter Return
+0.98%
1 Year Return
+29.32%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$86.1M
AUM Growth
+$86.1M
(-15%)
Cap. Flow
-$11.3M
Cap. Flow
% of AUM
-13.15%
Top 10 Holdings %
Top 10 Hldgs %
91.73%
Holding
23
New
2
Increased
4
Reduced
2
Closed
5
Top Buys
| 1 |
Delcath Systems
DCTH
|
$2.04M |
| 2 |
Milestone Pharmaceuticals
MIST
|
$1.16M |
| 3 |
Phathom Pharmaceuticals
PHAT
|
$909K |
| 4 |
Applied Therapeutics
APLT
|
$816K |
| 5 |
Compass Therapeutics
CMPX
|
$434K |
Top Sells
| 1 |
Ardelyx
ARDX
|
$4.82M |
| 2 |
Akero Therapeutics
AKRO
|
$4.65M |
| 3 |
Madrigal Pharmaceuticals
MDGL
|
$4.31M |
| 4 |
Kymera Therapeutics
KYMR
|
$2.27M |
| 5 |
Kura Oncology
KURA
|
$1.13M |
Sector Composition
| 1 | Healthcare | 67.17% |
| 2 | Energy | 31.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Plains GP Holdings
PAGP
$3.82B
| $27.2M | 31.57% | 1,272,360 | – | – |
|
|
2
Madrigal Pharmaceuticals
MDGL
$9.76B
| $9.95M | 11.56% | 30,032 -13,000 | -30% | -$4.31M |
|
|
3
Akero Therapeutics
AKRO
$3.74B
| $9.27M | 10.76% | 228,884 -114,845 | -33% | -$4.65M |
|
|
4
Phathom Pharmaceuticals
PHAT
$864M
| $7.12M | 8.27% | 1,134,927 +145,000 | +15% | +$909K |
|
5
Achieve Life Sciences
ACHV
$152M
| $6.55M | 7.61% | 2,453,092 | – | – |
|
|
6
Applied Therapeutics
APLT
$71M
| $5.52M | 6.41% | 11,285,420 +1,670,000 | +17% | +$816K |
|
7
Avidity Biosciences
RNA
$5.99B
| $5.27M | 6.12% | 178,500 | – | – |
|
8
Abeona Therapeutics
ABEO
$350M
| $2.97M | 3.45% | 624,022 | – | – |
|
9
TScan Therapeutics
TCRX
$102M
| $2.88M | 3.35% | 2,087,139 | – | – |
|
|
10
Delcath Systems
DCTH
$385M
| $2.26M | 2.63% | 177,600 +160,600 | +945% | +$2.04M |
|
11
Syndax Pharmaceuticals
SNDX
$1.41B
| $2.25M | 2.62% | 183,259 | – | – |
|
12
Zevra Therapeutics
ZVRA
$509M
| $1.35M | 1.57% | 179,874 | – | – |
|
|
13
Milestone Pharmaceuticals
MIST
$156M
| $1.16M | 1.35% | +1,451,557 | New | +$1.16M |
|
|
14
Compass Therapeutics
CMPX
$483M
| $434K | 0.5% | +228,317 | New | +$434K |
|
15
Athira Pharma
ATHA
$15.3M
| $425K | 0.49% | 1,492,792 | – | – |
|
|
EIGR
16
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $423K | 0.49% | 146,381 | – | – |
|
|
17
Ardelyx
ARDX
$1.53B
| – | – | -950,947 | Closed | -$4.82M |
|
|
CMPS
18
Compass Pathways
CMPS
$424M
| – | – | -25,209 | Closed | -$95.3K |
|
19
Jasper Therapeutics
JSPR
$45.5M
| – | – | -20,000 | Closed | -$428K |
|
|
20
Kura Oncology
KURA
$686M
| – | – | -130,000 | Closed | -$1.13M |
|
|
21
Kymera Therapeutics
KYMR
$2.95B
| – | – | -56,359 | Closed | -$2.27M |
|